Adult Grade 1 Meningioma — Trials

Adult Grade 1 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01125046	Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	completed	Phase 2	50	Northwestern UniversityOTHER	1	Jan 22, 2021	clinicaltrials
NCT00045110	Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma	completed	Phase 1 / Phase 2	136	National Cancer Institute (NCI)NIH	1	Aug 17, 2017	clinicaltrials
NCT00045734	Imatinib Mesylate in Treating Patients With Recurrent Meningioma	completed	Phase 2	23	National Cancer Institute (NCI)NIH	1	May 15, 2017	clinicaltrials
NCT01119599	RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Data updated 23 days agoSource updated Jan 22, 2021source: clinicaltrials